Debate: The slippery slope of surrogate outcomes
Surrogate outcomes are frequently used in cardiovascular disease research. A concern is that changes in surrogate markers may not reflect changes in disease outcomes. Two recent clinical trials (Heart and Estrogen/Progestin Replacement Study [HERS], and the Antihypertensive and Lipid-Lowering Treatm...
Uloženo v:
| Vydáno v: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2000
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59603/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714414/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-2-076 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|